Table 1.
Participant Characteristics
| Lottery | Fixed | Overall | |
|---|---|---|---|
| Sex, n | 31 | 28 | 59 |
| Male | 23 (74%) | 17 (61%) | 40 (68%) |
| Female | 8 (26%) | 11 (39%) | 19 (32%) |
| Ethnicity, n | 31 | 28 | 59 |
| Hispanic/Latino | 0 (0%) | 1 (4%) | 1 (2%) |
| Other | 31 (100%) | 27 (96%) | 58 (98%) |
| Race, n | 31 | 28 | 59 |
| White/Caucasian | 18 (58%) | 11 (39%) | 29 (49%) |
| Black/African American | 12 (39%) | 13 (46%) | 25 (42%) |
| Indian (American) | 0 (0%) | 1 (4%) | 1 (2%) |
| Mixed | 1 (3%) | 2 (7%) | 3 (5%) |
| Latin | 0 (0%) | 1 (4%) | 1 (2%) |
| Age (years), n | 31 | 28 | 59 |
| Median (Q1, Q3) | 55 (50, 60) | 54 (50, 58) | 54 (50, 60) |
| Mean (SD) | 55 (9) | 53 (10) | 54 (9) |
| Income, n | 31 | 28 | 59 |
| $0–$20000 | 24 (77%) | 17 (61%) | 41 (69%) |
| $21000–$40000 | 3 (10%) | 5 (18%) | 8 (14%) |
| $41000–$60000 | 4 (13%) | 1 (4%) | 5 (8%) |
| $61000–$80000 | 0 (0%) | 1 (4%) | 1 (2%) |
| Refused | 0 (0%) | 4 (14%) | 4 (7%) |
| Highest Level of Education, n | 30 | 28 | 58 |
| No. missing | 1 | 0 | 1 |
| Middle school (Jr. High) or less | 4 (13%) | 0 (0%) | 4 (7%) |
| Some high school, no diploma | 7 (23%) | 5 (18%) | 12 (21%) |
| High school graduate/GED or equivalent | 11 (37%) | 12 (43%) | 23 (40%) |
| Junior (2 year) college | 1 (3%) | 1 (4%) | 2 (3%) |
| Technical/trade/vocational school | 0 (0%) | 3 (11%) | 3 (5%) |
| Some college (4-year college or university) | 3 (10%) | 5 (18%) | 8 (14%) |
| College graduate (4-year college or university | 2 (7%) | 1 (4%) | 3 (5%) |
| Postcollege/graduate | 1 (3%) | 1 (4%) | 2 (3%) |
| Don’t know | 1 (3%) | 0 (0%) | 1 (2%) |
| Health Insurance Status, n | 31 | 28 | 59 |
| Insured | 25 (81%) | 21 (75%) | 46 (78%) |
| Uninsured | 6 (19%) | 7 (25%) | 13 (22%) |
| Housing Statusa, n | 31 | 28 | 59 |
| Stable | 18 (58%) | 21 (75%) | 39 (66%) |
| Unstable | 13 (42%) | 7 (25%) | 20 (34%) |
| HCV-RNA (log10 IU/mL), n | 31 | 27 | 58 |
| No. missing | 0 | 1 | 1 |
| Median (Q1, Q3) | 6.27 (5.67, 6.64) | 6.06 (5.22, 6.42) | 6.12 (5.66, 6.53) |
| Mean (SD) | 6.14 (0.75) | 5.95 (0.69) | 6.05 (0.72) |
| Liver Cirrhosis, n | 31 | 28 | 59 |
| Yes | 11 (35%) | 13 (46%) | 24 (41%) |
| No | 19 (61%) | 15 (54%) | 34 (58%) |
| Unknown | 1 (3%) | 0 (0%) | 1 (2%) |
| HCV Genotype, n | 31 | 28 | 59 |
| 1 | 26 (84%) | 27 (96%) | 53 (90%) |
| 2 | 5 (16%) | 1 (4%) | 6 (10%) |
| Documented HIV Status, n | 31 | 28 | 59 |
| Positive | 9 (29%) | 10 (36%) | 19 (32%) |
| Negative | 11 (35%) | 10 (36%) | 21 (36%) |
| Unknown | 11 (35%) | 8 (29%) | 19 (32%) |
| CES-D Score, n | 31 | 28 | 59 |
| Median (Q1, Q3) | 22 (17, 30) | 19 (15, 25) | 21 (15, 27) |
| Mean (SD) | 24 (10) | 21 (9) | 23 (10) |
| Current Drug-Use Statusb, n | 31 | 28 | 59 |
| Active | 12 (39%) | 15 (54%) | 27 (46%) |
| Not Active | 19 (61%) | 13 (46%) | 32 (54%) |
| Current Drug(s) Used, n | 31 | 28 | 59 |
| Marijuana | 11 (35%) | 10 (36%) | 21 (36%) |
| Hallucinogens | 2 (6%) | 1 (4%) | 3 (5%) |
| Cocaine/crack | 5 (16%) | 7 (25%) | 12 (20%) |
| Heroin | 2 (6%) | 2 (7%) | 4 (7%) |
| Street methadone | 0 (0%) | 1 (4%) | 1 (2%) |
| Prescription painkillersc | 1 (3%) | 7 (25%) | 8 (14%) |
| Methamphetamines | 2 (6%) | 0 (0%) | 2 (3%) |
| Stimulants | 2 (6%) | 1 (4%) | 3 (5%) |
| Tranquilizers/sedatives | 1 (3%) | 1 (4%) | 2 (3%) |
| Regimen, n | 31 | 28 | 59 |
| Ledipasvir/sofosbuvir | 14 (45%) | 14 (50%) | 28 (47%) |
| Ribavirin, ledipasvir/sofosbuvir | 1 (3%) | 0 (0%) | 1 (2%) |
| Ribavirin, sofosbuvir | 5 (16%) | 1 (4%) | 6 (10%) |
| Ribavirin, sofosbuvir, interferon | 3 (10%) | 1 (4%) | 4 (7%) |
| Ribavirin, sofosbuvir, simeprevir | 1 (3%) | 1 (4%) | 2 (3%) |
| Sofosbuvir, simeprevir | 7 (23%) | 11 (39%) | 18 (31%) |
Abbreviations: CES-D, Center for Epidemilogical Studies Depression; GED, General Education Diploma; HCV, hepatitis C virus; HIV, human immunodeficiency virus; RNA, ribonucleic acid; SD, standard deviation.
aHousing stability was defined as owning or renting a house or apartment.
bCurrent was defined to be in the past month.
cNarcotics available by prescription.